4th Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Period 4th Quarter 2011 Filed Dec 29, 2011 Signed by Melanie Nathanson, Partner

Official filing
Firm
RED+BLUE STRATEGIES
Client
PEW CHARITABLE TRUSTS
Income
$25,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation and rulemaking related to the Physician Payment Sunshine Act- a Medicare-related provision in the health reform law focused on systemic transparency.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Pharmacy PHA

H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act of 2011. Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act of 2011- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 2182 (112th), S. 1584 (112th), S. 1734 (112th), H.R. 3026 (112th)

Health Issues HCR

H.R. 2182/S.1734 - The Generating Antibiotic Incentives Now Act of 2011. Supporting work to increase innovation in the development of new antibiotics. S. 1584 - The Drug Safety and Accountability Act of 2011. Supporting upstream supply chain safety issues. S. 3026 - Safeguarding America's Pharmaceuticals Act of 2011. Supporting downstream supply chain issues. Implementation and rulemaking related to the Physician Payment Sunshine Act - A Medicare-related provision in the Health Reform Law focused on increasing systemic transparency. Work related to treatment of medical devices in the upcoming FDA user fee arena.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 3026 (112th), S. 1734 (112th), H.R. 2182 (112th), S. 1584 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.